September 07, 2016
The US Food and Drug Administration (FDA) issued a warning letter to Amniotic Therapies of Texas as vials of drugs tested positive for bacteria.
The agency also noted that it discovered that Amniotic Therapies did not have the proper procedures to prevent such contamination and did not test its products’ sterility.
Antibiotic Recalled Due to Iron Oxide Particulates
Crystallization Prompts Recall of Tissue Softeners
Were there adverse events associated with this? Yes. The FDA noted several adverse events, which included two infections that were a result of Mycoplasma hominis.
Earlier, the FDA attempted to have the company shut down, but a federal judge prevented it from doing so. Amniotic Therapies was ordered to “stop manufacturing human cells, tissues or cellular-tissue-based products (HCT/Ps) and recall and destroy all product made since Sept. 11, 2014,” according to a Mass Device report.
The Amniotic Therapies website is currently a single page announcing "scheduled maintenance."